Skip to search formSkip to main contentSkip to account menu

Carglumic acid

Known as: (S)-2-ureidopentanedioic acid, N-Carbamyl-L-glutamate, Ureidoglutaric acid 
An orally active, synthetic structural analogue of N-acetylglutamate (NAG) and carbamoyl phosphate synthetase 1 (CPS 1) activator, with ammonia… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
INTRODUCTION Valproic acid (VPA) is a drug mainly used to treat epilepsy. Hyperammonaemic encephalopathy due to VPA is a rare but… 
2016
2016
We present the unique case of adult hyperinsulinism hyperammonemia syndrome (HI/HA). This condition is rarely seen in children… 
2015
2015
Utilizing the mixed-ligand strategy, a novel fourfold-interpenetrated 3D homochiral metal-organic framework (1) with rare pair… 
2015
2015
This paper describes a systematic approach to overcoming challenges in developing a robust and selective liquid chromatography… 
2013
2013
T raber et al (1) recently reported a case of “Subacute bilateral visual loss in methylmalonic acidemia” in a 23-year-old woman… 
2010
2010
FDA on March 18 approved the marketing of carglumic acid, or Carbaglu, for the treatment of a rare genetic enzyme deficiency that… 
1963
1963
Summary1.Of the various carbon sources tested, glucose proved to be among the most suitable for both growth and flavinogenesis.2… 
1963
1963
Summary1.The cis-forms of higher, unsaturated fatty acids, oleic and erucic markedly stimulated riboflavin synthesis while the…